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article under the CC BY-NC-ND license (Abstract Background/purpose: Salvia miltiorrhiza (SM) Bunge (Labiatae/Lamiaceae; com-
mon name danshen) is a Chinese medicine that improves blood circulation and inhibits inflam-
matory response. Thus, it is used for the treatment of cardiac diseases and inflammation. In
this study, we aimed to evaluate the effect of an ethanolic extract of SM (SME) on the dental
alveolar bone resorption induced by bacterial lipopolysaccharide (LPS) in rats.
Materials and methods: An ethanolic extract was prepared from roots of SM. The major con-
stituents of this extract were determined by high-performance liquid chromatography. The ac-
tivity of the extract was evaluated in a rat model in which the dental alveolar bone resorption
was induced by injection of bacterial LPS into the palatal gingiva around the maxillary molar
teeth. The effect of SME on the bone resorption was studied by histologic and histomorpho-
metric analysis.
Results: The number of osteoclasts and the percentage of osteoclasts covering the alveolar
bone surfaces were significantly increased in the LPS group compared with those in the
phosphate-buffered saline (PBS) group. The number and percentage of the osteoclasts on
the bony surfaces were significantly reduced in the SME group in comparison with the LPS
group, although it was still higher than the numbers observed in the PBS group.ntistry, National Defense Medical Center and Tri-Service General Hospital, PO Box 90048-507, Taipei,
ax: þ886 2 87927145.
ed.net.tw (C.-Y. Chiang).
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SMEZ Salvia miltiorrhiza extract.Conclusion: Because SME reduced bone resorption caused by the injections of bacterial LPS in
rats, we suggest that SME might have a protective effect on dental alveolar bone resorption in
periodontitis.
Copyright ª 2015, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Periodontitis, a disease of the periodontium characterized
by destruction of tooth-supporting tissues, is caused by a
host-mediated inflammatory response to bacterial plaque
residing in gingival pockets and can eventually lead to tooth
loss.1 Several species of Gram-negative bacteria are known
to be key etiologic pathogens of periodontitis.2 These
bacteria, as well as their biological exudates, can induce
inflammatory cell infiltration, edema, and vascular dilata-
tion in inflamed tissues.3 Although the detailed pathogen-
esis of the disease is still being investigated, significant
effort is now focused on finding pharmacological agents
that can treat periodontitis by either acting against the
causative bacteria or reducing the host inflammatory
response.4
Dried roots of Salvia miltiorrhiza (SM) Bunge (Labiatae/
Lamiaceae; common name danshen) are listed in the Chi-
nese Pharmacopoeia as a treatment for cardiovascular
disease and inflammation.5 A water decoction of SM is re-
ported to be effective for improving reperfusion of
ischemic myocardium and enhancing blood circulation.6
Similarly, an ethanolic extract of SM (SME) inhibits the in-
flammatory response associated with myocardial infarction
and atherosclerosis.7,8 The potential anti-inflammatory ef-
fects of SME were evaluated both in vitro and in vivo. The
anti-inflammatory effects of SME on lipopolysaccharide
(LPS)-induced nitric oxide production and inducible nitric
oxide synthase expression in RAW 264.7 cells were
demonstrated previously. In addition, SME was shown to
significantly reduce inflammation on carrageenan- or
dextran-induced acute arthritis in rats.9 Results of antimi-
crobial studies indicated that the major portion of its ac-
tivity was due to the presence of tanshinones and phenolic
acids in its hairy roots.10 The mechanism of antimicrobial  4    5     6    7    8  
or the lipopolysaccharide-
e resorption in rats.
phosphate-buffered saline;activity of the hexane fraction of SM Bunge against Staph-
ylococcus aureus and methicillin-resistant S. aureus was
evidenced by its ability to inhibit the expression of the
resistant genes, mecA, mecR1, and femA, in messenger
RNA.11 Additional bioactivities of the SM have also been
reported, including antineoplasmic and antiosteoporotic
effects.12,13 Recently, it has been reported that SME can
ameliorate the effect of periodontal damage induced by
silk ligation around the tooth neck area in a rat model.14 We
herein evaluated whether the ethanolic SME could inhibit
bone resorption in rats with the experimental periodontitis
induced by LPS injection; the antimicrobial effect of
ethanolic SME was not considered in this study.14
Materials and methods
Preparation of the ethanolic extract of SM root
SME was prepared as described previously.15 In brief, 1 kg of
dried SM roots were pulverized and soaked in 10 L of 95%
ethanol for 72 hours at room temperature. The extract was
filtered and concentrated by evaporation under vacuum.
The resulting solid residue was soaked in 95% ethanol (10 L)
for 48 hours, filtered, and then concentrated again. This
soakefiltereevaporation process was repeated two more
times, and the filtrates were evaporated to dryness,
yielding 100.3 g of crude SME (10% yield). A quantitative
analysis of SME was carried out by reverse-phase high-per-
formance liquid chromatography (Waters XBridge Shield
RP18, Hitachi, Tokyo, Japan, 5 mm, 4.6 mm  250 mm)
using a mobile phase of 75% acetonitrile/25% H2O at a flow
rate of 1.0 mL/min with an injection volume of 10 mL and a
UV detection wavelength of 254 nm. The extract was then
dissolved in 10% Tween 80 for the in vivo experiment.
LPS-induced osteoclast resorption from the dental
alveolus of rats
The effect of SME on LPS-induced osteoclast resorption
from the dental alveolus was evaluated after adminis-
tering injections of Escherichia coli LPS [dissolved in
phosphate-buffered saline (PBS) solution, 5 mg/mL, E. coli
serotype 055:B5; Sigma Co., St. Louis, MO, USA] into the
palatal gingiva of rats as described previously.16e18 In
brief, 15 rats were randomly divided into the following
three treatment groups based on the treatment they
received: PBS, LPS, and SME treatment groups. Rats in the
PBS treatment group received a 10-mL PBS injection daily
for 3 days; rats in the LPS treatment group received a 10-
mL LPS (5 mg/mL) injection for 3 days; and rats in the SME
group received the same LPS injections for 3 days and a
Danshen on periodontal destruction of rat 37daily 300 mg/kg intraperitoneal dose of SME for 7 days,
beginning 1 day prior to the 1st day of LPS injection. At the
end of the 7-day treatment period, all animals in the three
groups were killed and palatal specimens were taken and
prepared for histologic analysis (Figure 1). In this study, all
animals were housed in a dedicated, pathogen-free facil-
ity and were handled in accordance with protocols
approved by the Institutional Animal Care and Use Com-
mittee, National Defense Medical Center, Taipei, Taiwan
(IACUC-11-033).Histology and histometric analysis
After fixation, the specimens were decalcified with 14%
EDTA and embedded in paraffin. The maxillary specimens
were then cut into 4-mm-thick sections in the bucco-palatal
direction. All sections were routinely stained with hema-
toxylin and eosin (H&E). Tartrate-resistant acid phospha-
tase (TRAP) staining was further performed on the each
section to determine the level of active osteoclasts on the
bony surface. The TRAP solution was prepared as follows:
9.6 mg naphthol AS-BI phosphate substrate (Sigma) was
dissolved in 0.6 mL N,N-dimethylformamide (Sigma) with
60 mL of 0.2M sodium acetate buffer (pH 5.0, Sigma) con-
taining 84 mg of Fast red-violet LB diazonium salt (Sigma),
58.2 mg of tartaric acid (Sigma), and 240 mL of 10% MgCl2.
The mixture was then filtered through a 0.22-mm pore-size
filter. Slides were incubated for 5 minutes in the staining
solution at 37C in the dark. Afterward, the slides wereFigure 2 Quantitative analysis of crude Salvia miltiorrhiza extr
substituent. The quantitative analysis of SME was performed by rev
detection wavelength of 254 nm. Upon comparison with authentic s
30% tanshinone IIA, 5.8% cryptotanshinone, and 2.8% tanshinone Iwashed with water for 30 minutes, and then counterstained
with H&E for 6 minutes.19
A total of eight slides were selected from the 40 slides of
each specimen (three sections on one slide) for histologic
and histometric analysis. The number of TRAP-positive os-
teoclasts with three or more nuclei on the palatal bony
lacunae identified in the area between the bone crest and
the great palatine vessels were recorded.16,20 The bone
resorption was quantified statistically in terms of the
number of osteoclasts (number of osteoclasts/alveolar
bone surface, no./mm) and the percentage of the bone
surface covered with osteoclasts (osteoclast surface/alve-
olar bone surface, %).21e23
Statistical analysis
All data were analyzed using a statistical software pack-
age (SPSS version 15.0, IBM, Chicago, IL, USA). The effect
of SME on the number of osteoclasts measured on sur-
faces of dental alveolar bones in the three study groups
was examined by one-way analysis of variance and
analyzed with a Duncan test (post hoc). A P value less
than 0.05 was considered to indicate a significant
difference.
Results
The major components of 95% ethanolic SME were deter-
mined by comparison with authentic standards. In thisact (SME) and authentic standards for retention time of each
erse-phase high-performance liquid chromatography with a UV
tandards (AeC), the major SME components were identified as
(D).
38 H.-T. Tsai et alstudy, the major components were 30% tanshinone IIA, 5.8%
cryptotanshinone, and 2.8% tanshinone I (Figure 2).
On the palatal bony surface in specimens from rats in the
PBS control group, we observed a small number of osteo-
blasts with osteoid underneath (Figure 3A). By contrast,
many TRAP-positive-stained osteoclasts with resorptive
lacunae were observed in specimens from rats in the LPS
group (Figure 3B). Importantly, the number of osteoclasts
was significantly reduced by SME treatment compared with
the LPS group, although it was still higher than that
observed in the PBS group (Figures 3C and 3D).PBS LPS LPS+SMEN
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SME, especially tanshinone IIA as an active component of
the ethanolic extracts, is a very popular medicinal formu-
lation that has been extensively used to treat various dis-
eases, such as myocardial infarction and atherosclerosis.7,8
However, in other extraction processes using a ratio of
water to raw SM, polysaccharides were reported as the
main antioxidant component.24 In two previous studies,
higher amounts of tanshinones were obtained with a higher
percentage of ethanol extract, and this component wasPBS LPS LPS+SME
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saccharide (LPS)-induced osteoclast resorption on the dental
hosphate-buffered saline (PBS), LPS (5 mg/mL), and LPS þ SME
shown at 200 and 40 magnifications in the upper and lower
lasts (number of cells/mm) and the percentage of osteoclasts-
cant difference at P < 0.05).
Danshen on periodontal destruction of rat 39used as an ingredient in health-care foods to improve the
effectiveness of chemotherapeutic agents of cancer25 and
drugs for cardiovascular protection.26 In our study, about
30% tanshinone IIA, 5.8% cryptotanshinone, and 2.8% tan-
shinone I were obtained by using 95% ethanol extract,
which demonstrated the inhibitory effect of SME on LPS-
induced alveolar bone resorption. These data indicate
that using the ethanol fraction of SM increases the amounts
of tanshinones obtained, which exhibits significant anti-
inflammatory and bone resorption inhibition effects.
The SME also inhibited dental alveolar bone resorption
induced by the trans-gingival injection of bacterial LPS in
our study. Several previous studies have also shown that
periodontitis and associated tissue destruction can be
induced in animals by dietary manipulation,27 injection of
bacterial toxins,14 placement of peri-dental silk ligatures or
orthodontic elastics for bacterial colonization, or surgical
removal of alveolar bone.28 Each type of induced peri-
odontitis has certain experimental limitations. The ligation-
induced periodontitis, for instance, is thought to cause
abnormally exaggerated plaque retention and potential
trauma to the local gingival tissue. Although LPS-induced
periodontitis model is utilized herein, it does not
completely replicate the chronic characteristics of the
bacteria-associated periodontitis. However, the presence
of the foreign body in the ligation model could prevent the
attenuation of the inflammatory process after the treat-
ment agent is tested for use.18 Recently, it has been re-
ported that SME can ameliorate the effect of periodontal
damage induced by silk ligation around the tooth neck area
in a rat model. To further exclude the antimicrobial activ-
ities of SMEs reported in literature,11 the trans-gingival
delivery of bacterial LPS was chosen to be used in this
study.
Several species of Gram-negative bacteria, including
Porphyromonas gingivalis, are known to be the etiologic
pathogens of periodontitis.2,29 However, the LPS of the
bacteria is the key inflammatory mediator, which causes a
highly unusual host response. Some studies have suggested
that P. gingivalis LPS has an ability to stimulate cytokine
production comparable to that of E. coli, whereas others
suggest a much lower potency, including a lower activity in
stimulating some cytokines [interleukin-1 (IL-1), tumor
necrosis factor-a (TNF-a), and prostaglandin E2] but a
comparable activity in stimulating others (IL-6, IL-1ra). In
addition, LPS from P. gingivalis binds lipopolysaccharide-
binding protein 10e100 times less efficiently than that
from E. coli; additionally, P. gingivalis LPS does not interact
with toll-like receptors in the same manner as E. coli LPS
does.30 Nevertheless, the effect of P. gingivalis, rather than
E. coli, on the bone resorption of this model needs further
evaluation.
Our result indicated that treatment with SME signifi-
cantly reduced bone resorption compared with the control
group. This observation is consistent with previous studies,
in which SME suppressed bone loss caused by ovariec-
tomy.31,32 SME was also found to stimulate bone formation
within a collagen matrix surrounding surgically created
parietal bone defects in New Zealand white rabbits.33 The
authors of that study suggested that SME could be useful for
bone grafting, especially in cases with a compromised
vascular response. These previous reports are consistentwith our finding that SME has an ameliorative effect on
dental alveolar bone resorption associated with periodon-
titis. Although the detailed mechanism for this effect was
not explored in this study, other studies have documented
the bioactivity of SME toward osteoblasts, osteoclasts, and
macrophages. For example, purified tanshinone IIA, a major
lipophilic ingredient of SME, inhibits the production of
bacterial LPS-induced inflammatory mediators of prosta-
glandin E2, inducible nitric oxide, and cyclooxygenase-2, as
well as inflammatory cytokines in osteoblasts and macro-
phages (e.g., IL-1b, IL-6, and TNF-a).34e36 SME has also
been shown to inhibit LPS-induced nuclear factor-kB acti-
vation in osteoclasts.37 Finally, several other lipophilic
tanshinones are known to inhibit osteoclast differentia-
tion38 or LPS-induced inflammatory cytokine production.39
All of these activities suggest that the mechanism by
which SME exerts anti-inflammatory and antiresorptive ac-
tivity could involve repression of inflammatory signaling. In
our study, the antiresorptive effect may have partially
resulted from components in SME, particularly tanshinones
IIA, which constituted 30% of the major SME components;
however, this component is lipophilic and has poor oral
bioavailability owing to its low water solubility.40 There-
fore, it is necessary to identify hydrophilic substances in
SME, so that the extract could be administered orally (per
os).
Our results show a statistically significant inhibitory ef-
fect of SME on LPS-induced alveolar bone resorption. We
therefore suggest that SME merits further evaluation as an
inhibitor of alveolar bone loss caused by bacteria-
associated periodontal disease.Conflicts of interest
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